Menu
GeneBe

6-38594028-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001099272.2(BTBD9):c.485G>T(p.Cys162Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,461,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

BTBD9
NM_001099272.2 missense

Scores

5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.89
Variant links:
Genes affected
BTBD9 (HGNC:21228): (BTB domain containing 9) This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25462115).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BTBD9NM_001099272.2 linkuse as main transcriptc.485G>T p.Cys162Phe missense_variant 3/11 ENST00000481247.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BTBD9ENST00000481247.6 linkuse as main transcriptc.485G>T p.Cys162Phe missense_variant 3/115 NM_001099272.2 P1Q96Q07-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000802
AC:
2
AN:
249458
Hom.:
0
AF XY:
0.00000739
AC XY:
1
AN XY:
135346
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1461790
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000894
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000378
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 13, 2023The c.485G>T (p.C162F) alteration is located in exon 4 (coding exon 2) of the BTBD9 gene. This alteration results from a G to T substitution at nucleotide position 485, causing the cysteine (C) at amino acid position 162 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
0.010
T
BayesDel_noAF
Uncertain
-0.050
Cadd
Benign
22
Dann
Benign
0.95
Eigen
Benign
0.13
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.88
D;.;D;D;D;D;T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.25
T;T;T;T;T;T;T
MetaSVM
Benign
-0.86
T
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Uncertain
0.79
T
PROVEAN
Benign
-1.4
N;N;.;N;.;N;N
REVEL
Benign
0.28
Sift
Benign
0.63
T;T;.;T;.;T;T
Sift4G
Benign
0.65
T;T;.;T;T;T;T
Polyphen
0.88
.;P;P;.;.;.;.
Vest4
0.81
MutPred
0.50
.;Loss of catalytic residue at M160 (P = 0.0799);Loss of catalytic residue at M160 (P = 0.0799);.;.;Loss of catalytic residue at M160 (P = 0.0799);.;
MVP
0.78
MPC
0.51
ClinPred
0.38
T
GERP RS
5.7
Varity_R
0.40
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs770637025; hg19: chr6-38561804; API